Explore Books on
drug screening

Computer techniques in preclinical and clinical drug development

By Jackson, Robert C.

Drug Development Process

By Peter Welling

Histopathology of preclinical toxicity studies

By P. Greaves

Screening for biological response modifiers

By James E. Talmadge

Accelerating CNS drug development

By Neal R. Cutler,John J. Sramek,Neil M. Kurtz,Michael F. Murphy,Angelico Carta

Progress in genetic toxicology

By International Conference on Environmental Mutagens (2nd 1977 Edinburgh, Scotland)

Carcinogenesis testing of chemicals

By Conference on Carcinogenesis Testing in the Development of New Drugs Washington, D.C. 1973.

PET for Drug Development and Evaluation (Developments in Nuclear Medicine)

By D. Comar

Cytotec

By Tim Phelps

Drug metabolism

By International Union of Pure and Applied Chemistry

Interferon alpha-2

By John F. Smyth

Drug bioscreening

By Emmanuel B. Thompson

Behavioural models in psychopharmacology

By Paul Willner

Acute toxicology testing

By Shayne C. Gad

Radiation sensitizers, their use in the clinical management of cancer

By Conference on Combined Modality Cancer Treatment--Radiation Sensitizers and Protectors (1973 Key Biscayne, Fla.)

Anticonvulsant screening project

By National Institute of Neurological and Communicative Disorders and Stroke. Epilepsy Branch.

Imaging techniques in medications development

By Heinz Sorer,Rao S. Rapaka

Anticancer drug development guide

By Beverly A. Teicher

Animal models in radiotracer design

By Richard M. Lambrecht,William C. Eckelman

Decision making in drug research

By F. H. Gross,T. B. Binns

Radiation sensitizers, their use in the clinical management of cancer

By Conference on combined modality cancer treatment--radiation sensitizers and protectors (1979 Key Biscayne)

Challenges and issues in high throughput screening

By Conference on Challenges and Issues in High Throughput Screening: A Pharmaceutical and Agrochemical Industry Perspective (1997 Manchester Conference Centre)

Predictive value of carcinogenicity testing in drug evaluation

By Nordic Workshop on Toxicology (1986 Sigtuna, Sweden)

Multinational drug companies

By Bert Spilker